ADC THERAPEUTICS SA shareholders Q1 2023

ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 61 filers reported holding ADC THERAPEUTICS SA in Q1 2023. The put-call ratio across all filers is 16.86 and the average weighting 0.2%.

ADC THERAPEUTICS SA shareholders Q1 2023
NameSharesValueWeighting ↓
IHT Wealth Management, LLC 15,110$29,4660.00%
Magnetar Financial LLC 55,762$108,7360.00%
MILLENNIUM MANAGEMENT LLC 1,793,192$3,4970.00%
Prospera Financial Services Inc 12,623$24,6140.00%
FRED ALGER MANAGEMENT, LLC 125,985$245,6710.00%
Qube Research & Technologies Ltd 77,166$150,4740.00%
Squarepoint Ops LLC 104,547$203,8670.00%
JPMORGAN CHASE & CO 3,091,814$6,029,0000.00%
MARSHALL WACE, LLP 157,679$307,4750.00%
Citadel Advisors 3,366,704$6,565,0730.00%
TWO SIGMA INVESTMENTS, LP 223,827$436,4630.00%
MONETA GROUP INVESTMENT ADVISORS LLC 19,496$38,0170.00%
GOLDMAN SACHS GROUP INC 2,353,705$4,589,7250.00%
AMERIPRISE FINANCIAL INC 112,906$220,1670.00%
SALEM INVESTMENT COUNSELORS INC 35$690.00%
MORGAN STANLEY 437,949$854,0010.00%
Cutler Group LLC / CA 1,400$20.00%
ROYAL BANK OF CANADA 7,003$14,0000.00%
BlackRock Inc. 635,547$1,239,3160.00%
Citadel Advisors 700$1,3650.00%
External links

This page lists ADC THERAPEUTICS SA's shareholders in Q1 2023. To view ADC THERAPEUTICS SA's shareholder history, click here.